At present, the new crown epidemic is still spreading globally, and local clusters of epidemics have occurred in local areas in China. In order to do a good job in the regular prevention and control of the new crown epidemic, vaccination is not only a personal matter, but also concerns the health of the whole family, school safety and social stability. At present, in addition to the population over 18 years old with no special contraindications, the national authorities have approved the emergency use of the inactivated vaccine for the new crown virus produced by Sinopharm Zhongsheng Company Beijing and Beijing Kexing Zhongwei Biotechnology Co. Each region arranged according to the actual situation, for example, Beijing launched the vaccination of 15-17 years old people on July 20, and the vaccination of 12-14 years old people at the beginning of August. Shandong is going to start planned vaccination of students aged 15-17 and 12-14 years old with the new crown vaccine in early August. According to the clinical trial data, the neutralizing antibody positive conversion rate was 100% in the 3-17 years old group, and there was no significant difference in the neutralizing antibody GMT and positive conversion rate compared with the adult group; in terms of safety, the safety after vaccination was good. For some special groups of people, the details of whether they can be vaccinated with the new crown vaccine are as follows: – People aged 60 years and above Currently, data from clinical studies show that the safety of vaccination is good in this group, so vaccination is also recommended for people aged 60 years and above. – Women of childbearing age and breastfeeding Women who are planning to become pregnant do not need to delay their pregnancy plans solely because of vaccination. If you become pregnant after vaccination or if you become pregnant in an unknown situation, a good pregnancy checkup and follow-up is sufficient. There are no data on the effect of vaccination of breastfeeding women with the new crown vaccine on nursing children, but it is recommended that breastfeeding women continue to breastfeed after vaccination due to the safety of the vaccine. – Chronic disease population Surveys have shown that chronically ill patients have a higher risk of hospitalization for co-infection with NCCV, such as those with hypertension and diabetes, and that chronically ill patients are at high risk of serious illness and death from NCCV infection. It is recommended that some patients with hypertension, diabetes, hepatitis B and other diseases be considered for vaccination against NCCV if their disease is well controlled. – Allergic groups Vaccination is not recommended when there is “allergy to the active ingredients of the vaccine, any of the inactive ingredients, substances used in the production process, or previous allergy to similar vaccines; previous severe allergic reactions to the vaccine”. Since penicillin allergy is not a contraindication to vaccination, the vaccine can be given to patients with New Crown. Urticaria can also be vaccinated if it is not in an acute phase, but it is recommended to consult a health care provider before vaccination. – For people with impaired immune function, inactivated vaccine and recombinant subunit vaccine are recommended; for adenovirus vector vaccine, the individual should be informed by a physician and the benefits should be weighed against the risks. – Patients or infected persons with previous neoconiosis Patients with previous neoconiosis virus infection (patients or asymptomatic infected persons) may receive one dose after 6 months of infection based on adequate notification.